LMATLEMAITRE VASCULAR INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $250M
- 14% YoY
- Operating margin
- 27.2%
- 14% YoY
- EBITDA
- $78M
- 27% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear141% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear25% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear10% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $154M | $162M | $193M | $220M | $250M | 14% |
| Operating income | $36M | $27M | $37M | $52M | $68M | 30% |
| Net income | $27M | $21M | $30M | $44M | $58M | 31% |
| Operating cash flow | $35M | $25M | $37M | $44M | $81M | 84% |
| Capex | $5M | $3M | $7M | $7M | $7M | 2.6% |
| Stock-based comp | $3M | $4M | $5M | $7M | $8M | 19% |
| Buybacks | $802K | $642K | $853K | $2M | $2M | 5.9% |
| Dividends | $9M | $11M | $12M | $14M | $18M | 26% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $357K · 1
- Net
- −$357K
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $3.8B | $4.2B | 210000 | 116000 |
| FY2024 | $3.2B | $8.3B | 236000 | 109000 |
| FY2023 | $2.2B | $4.4B | 144000 | 100000 |
| FY2022 | $1.9B | $2.4B | 116000 | 97000 |
| FY2021 | $2.0B | $5.3B | 125000 | 121000 |